← All stocks

Indivior Pharmaceuticals, Inc.

INDV Net buying

CIK 0001625297 #1439 in the set updated 17 Sep 2026

Bought (1 mo)

$53.54K

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$53.54K

+$53.54K against sales at will

By person

13 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Anderson Woodrow D

Chief Accounting Officer

$53.54K (1)

—

+$53.54K

27,638

0.0234%

$986.40K

+529.6%

Ciaffoni Joseph

Chief Executive Officer

—

790,330

0.6697%

$28.21M

+1,311%

Preblick Ryan

Chief Financial Officer

—

284,751

0.2413%

$10.16M

+1.5%

Heidbreder Christian

Chief Scientific Officer

—

209,337

0.1774%

$7.47M

+33.2%

Burris Jeffrey W

Chief Legal Officer

—

71,518

0.0606%

$2.55M

+9,310%

Barry Patrick A

Chief Commercial Officer

—

31,380

0.0266%

$1.12M

—

Wheadon David E.

Director

—

30,780

0.0261%

$1.10M

+143.8%

NINIVAGGI DANIEL A

Director

—

27,163

0.0230%

$969.45K

+68.2%

Stejbach Mark

Director

—

27,087

0.0230%

$966.74K

+68.5%

Humphreys Keith

Director

—

16,042

0.0136%

$572.54K

+219.1%

Thompson Juliet

Director

—

12,973

0.0110%

$463.01K

+237.0%

Ryan Barbara

Director

—

12,242

0.0104%

$436.92K

+930.5%

Kingsley Stuart A

Director

—

12,100

0.0103%

$431.85K

+1,215%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 7 Jan 2026